换一批
换一批PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
第一作者：
X,Bian
第一单位：
Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
作者：
主题词
氨基吡啶类(Aminopyridines);动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 子宫内膜样(Carcinoma, Endometrioid);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);抗药性, 肿瘤(Drug Resistance, Neoplasm);子宫内膜肿瘤(Endometrial Neoplasms);子宫内膜(Endometrium);女(雌)性(Female);人类(Humans);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);吗啉类(Morpholines);肿瘤, 实验性(Neoplasms, Experimental);PTEN磷酸水解酶(PTEN Phosphohydrolase);酞嗪类(Phthalazines);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);球形体, 细胞(Spheroids, Cellular)
DOI
10.1038/onc.2017.326
PMID
28945226
发布时间
2019-12-10
- 浏览12
Oncogene
341-351页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
